All Title Author
Keywords Abstract

PLOS ONE  2012 

Executive Control of Attention in Narcolepsy

DOI: 10.1371/journal.pone.0033525

Full-Text   Cite this paper   Add to My Lib


Background Narcolepsy with cataplexy (NC) is a disabling sleep disorder characterized by early loss of hypocretin neurons that project to areas involved in the attention network. We characterized the executive control of attention in drug-free patients with NC to determine whether the executive deficits observed in patients with NC are specific to the disease itself or whether they reflect performance changes due to the severity of excessive daytime sleepiness. Methodology Twenty-two patients with NC compared to 22 patients with narcolepsy without cataplexy (NwC) matched for age, gender, intellectual level, objective daytime sleepiness and number of sleep onset REM periods (SOREMPs) were studied. Thirty-two matched healthy controls were included. All participants underwent a standardized interview, completed questionnaires, and neuropsychological tests. All patients underwent a polysomnography followed by multiple sleep latency tests (MSLT), with neuropsychological evaluation performed the same day between MSLT sessions. Principal Findings Irrespective of diagnosis, patients reported higher self-reported attentional complaints associated with the intensity of depressive symptoms. Patients with NC performed slower and more variably on simple reaction time tasks than patients with NwC, who did not differ from controls. Patients with NC and NwC generally performed slower, reacted more variably, and made more errors than controls on executive functioning tests. Individual profile analyses showed a clear heterogeneity of the severity of executive deficit. This severity was related to objective sleepiness, higher number of SOREMPs on the MSLT, and lower intelligence quotient. The nature and severity of the executive deficits were unrelated to NC and NwC diagnosis. Conclusions We demonstrated that drug-free patients with NC and NwC complained of attention deficit, with altered executive control of attention being explained by the severity of objective sleepiness and global intellectual level. Further studies are needed to explore whether medications that promote wakefulness can improve the executive functions in narcolepsy.


[1]  Dauvilliers Y, Arnulf I, Mignot E (2007) Narcolepsy with cataplexy. Lancet 369: 499–511.
[2]  Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39–40.
[3]  Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, et al. (2001) CSF ypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57: 2253–2258.
[4]  Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, et al. (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59: 1553–1562.
[5]  Ervik S, Abdelnoor M, Heier MS, Ramberg M, Strand (2006) Health-related quality of life in narcolepsy. Acta Neurol Scand 114: 198–204.
[6]  Teixeira VG, Faccenda JF, Douglas NJ (2004) Functional status in patients with narcolepsy. Sleep Med 5: 477–483.
[7]  Vignatelli L, D’Alessandro R, Mosconi P, Delaj L, D’Alessandro R (2004) Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med 5: 467–475.
[8]  Dodel R, Peter H, Spottke A, Noelker C, Althaus A, et al. (2007) Health-related quality of life in patients with narcolepsy. Sleep Med 8: 733–741.
[9]  Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, et al. (2003) CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 74: 1667–1673.
[10]  Broughton WA, Broughton RJ (1994) Psychosocial impact of narcolepsy. Sleep 17: S45–49.
[11]  Dodel R, Peter H, Walbert T, Spottke A, Noelker C, et al. (2004) The socioeconomic impact of narcolepsy. Sleep 27: 1123–1128.
[12]  Strauss E, Sherman EMS, Spreen O (2006) A Compendium of Neuropsychological Tests. In: Administration , norms , editors. and commentary. 5th ed. New York: Oxford University Press.
[13]  Fernandez-Duque D, Posner MI (2001) Brain imaging of attentional networks in normal and pathological states. J Clin Exp Neuropsychol 23. pp. 74–93.
[14]  de Lecea L, Jones BE, Boutrel B Borgland SL, Nishino S, et al. (2006) Addiction and arousal: alternative roles of hypothalamic peptides. J Neurosci 2006 26. pp. 10372–1075.
[15]  Bayard S, Abril B, Yu H, Scholz S, Carlander B, et al. (2011) Decision making in narcolepsy with cataplexy. Sleep 34: 99–104.
[16]  Delazer M, H?gl B, Zamarian L, Wenter J, Gschliesser V, et al. (2011) Executive functions, information sampling, and decision making in narcolepsy with cataplexy. Neuropsychology 25: 477–487.
[17]  Fronczek R, Middelkoop HA, van Dijk JG, Lammers GJ (2006) Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep 29: 187–191.
[18]  Naumann A, Bellebaum C, Daum I (2006) Cognitive deficits in narcolepsy. J Sleep Res 15: 329–338.
[19]  Aguirre M, Broughton R, Stuss D (1985) Does memory impairment exist in narcolepsy-cataplexy? J Clin Exp Neuropsychol 7: 14–24.
[20]  Henry GK, Satz P, Heilbronner RL (1993) Evidence of a perceptual-encoding deficit in narcolepsy? Sleep 16: 123–127.
[21]  Pollak CP, Wagner DR, Moline ML, Monk TH (1992) Cognitive and motor performance of narcoleptic and normal subjects living in temporal isolation. Sleep 15: 202–211.
[22]  Rieger M, Mayer G, Gauggel S (2003) Attention deficits in patients with narcolepsy. Sleep 26: 36–43.
[23]  Baddeley AD (1996) Exploring the central executive. Q J Exp Psychol 49A: 5–28.
[24]  Norman DA, Shallice , T (1984) Attention to action: Willed and automatic control of behavior. Davidson RJ, Schwartz GE, Shapiro D, eds. Consciousness and self-regulation. New York: Plenum Press. pp. 1–17.
[25]  Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, et al. (2000) The unity and diversity of executive functions and their contributions to complex “Frontal Lobe” tasks: a latent variable analysis. Cogn Psychol 41: 49–100.
[26]  The International Classification of Sleep Disorders (2005) 2nd edition: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine.
[27]  Diagnostic , Statistical Manual of Mental Disorders (2004) American Psychiatric Association: Washington DC.
[28]  Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540–545.
[29]  Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, et al. (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28: 113–121.
[30]  Iber C, Ancoli-Israel S, Chesson A, Quan S, for the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events; rules, terminology and technical specifications. 1st ed Westchester, IL: American Academy of Sleep Medicine.
[31]  Beck AT, Steer RA, Brown GK (1998) Inventaire de dépression de Beck. Paris, France: Les Editions du Centre de Psychologie Appliquée.
[32]  Mackinnon A, Mulligan (2005) The estimation of premorbid intelligence levels in French speakers. Encephale 31: 31–43.
[33]  Van der Linden M, Wijns C, Von Frenkell R (1989) Un questionnaire d’auto-évaluation de l’attention (QAA). Bruxelles, Belgique: Editest.
[34]  Zimmermann , P , Fimm , B (2005) Testbatterie zur Aufmerkamkeitsprüfung (TAP). Würselem, Germany: Psytest.
[35]  Collette F, Van der Linden M (2002) Brain imaging of the central executive component of working memory. Neurosci Biobehav Rev 26: 105–125.
[36]  Collette F, Van der Linden M, Laureys S, Delfiore G, Degueldre C, et al. (2005) Exploring the unity and diversity of the neural substrates of executive functioning. Hum Brain Ma 25: 409–423.
[37]  Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, et al. (2003) The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med 4: 7–12.
[38]  Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, et al. (2002) CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 11: 91–93.
[39]  Friedman NP, Miyake A, Corley RP, Young SE, Defries JC, et al. (2006) Not all executive functions are related to intelligence. Psychol Sci 17: 172–179.
[40]  Becker PM, Schwartz JR, Feldman NT, Hugues RJ (2004) Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl) 171: 133–139.
[41]  Verstraeten E, Cluydts R (2004) Executive control of attention in sleep apnea patients: theoretical concepts and methodological considerations. Sleep Med Rev 8: 257–267.
[42]  Sturm W, Willmes K (2001) On the functional neuroanatomy of intrinsic and phasic alertness. Neuroimage 14: S76–84.
[43]  Thiel CM, Zilles K, Fink GR (2004) Cerebral correlates of alerting, orienting and reorienting of visuospatial attention: an event-related fMRI study. Neuroimage 21: 318–328.
[44]  Ratcliff R, Van Dongen HP (2009) Sleep deprivation affects multiple distinct cognitive processes. Psychol Bull Rev 16: 742–751.
[45]  Fulda S, Schulz H (2001) Cognitive dysfunction in sleep disorders. Sleep Med Rev 5: 423–445.


comments powered by Disqus